SS Innovations Says it Completed a Human Factors Validation Study for SSi Mantra Surgical Robotic System in September

MT Newswires Live
2025/10/02

SS Innovations International (SSII) said Thursday it completed a human factors validation study for its SSi Mantra surgical robotic system at Johns Hopkins Hospital in September.

The purpose of the study was to provide evidence the SSi Mantra meets the US Food and Drug Administration's requirements for usability and patient safety, the company said.

The company said it expects to submit a 510(k) premarket notification to the FDA for SSi Mantra in Q4.

The company said it could receive FDA clearance to market SSi Mantra in H1 2026, based on standard review timelines.

Price: 6.90, Change: -0.20, Percent Change: -2.82

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10